AF prescribing guidance
Prescribing guidance helps to ensure that patients receive consistent medications and therapies. Guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer.
Data and audits ensure we make evidence-based improvements to care. Data and audit information will be added here.
- SEL Atrial Fibrillation Primary Care Guidance (SEL APC, 06, 2025)
- Prescribing Dronedarone for the maintenance of sinus rhythm after successful cardioversion of atrial fibrillation (SEL APC, 03/2020)
- Notification of initiation to GP of DOAC therapy for stroke prevention in (nonvalvular) AF (SEL APC, 02/2024)
- SEL DOAC therapy FAQs (SEL IMOC, 01/2024)

